Q1 2024 Arcticzymes Technologies ASA Earnings Call Transcript
It's a rather early start for me. So I apologize if I sound a bit more tired and look a bit more tired than usual, but I'm sure we're going to get through this presentation in good style. I'm in the US because I'm attending a very important Congress. I am here together with our commercial team. It's the American Society of Gene and Cell Therapy that is going to kick off today, yesterday was the opening reception, and it's great to see that the industry is still driving spend some difficult years.
But the first talks I had with the partners and clients yesterday showed that there's a cautious optimism in a sector that has been hit rather hard during the last the year. We have a presentation for you today and Børge, if I can ask you to switch to the next slide. Thank you. A quick look at the agenda. I'm going to start off by giving you an overview of the company. We have a lot of new people joining us each time we do these presentations. So just a quick run-through of ArcticZymes and the journey we are on.
Now I'm going
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
